Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
21.51
+0.16 (0.75%)
At close: Oct 30, 2026, 4:00 PM EDT
21.48
-0.03 (-0.15%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $7.49 billion as of October 30, 2026. It is the 2,617th most valuable company in the world and the 909th biggest in the United States. Its market cap has increased by 131.81% in one year.
Market Cap
7.49B
Enterprise Value
10.15B
1-Year Change
131.81%
Global Rank
Country Rank
#909 United States
Category
ChartMarket Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has increased from $5.76B to $7.49B, an increase of 30.06%. That is a compound annual growth rate of 3.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 6.82B | 72.13% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 14.85B |
| Dr. Reddy's Laboratories | 11.90B |
| Elanco Animal Health | 11.52B |
| Alkermes | 7.61B |
| Kiniksa Pharmaceuticals International, | 7.25B |
| Lantheus Holdings | 6.56B |
| Hims & Hers Health | 6.46B |
| Indivior Pharmaceuticals | 4.17B |